Methadone Maintenance and the Likelihood of Risky Needle-Sharing

References

• Abdul-Quader A. S., Friedman S. R., Des Jarlais D. Methadone maintenance and behavior by intravenous drug users that can transmit HIV. Contemp. Drug Prob. 1987; 14: 425–434
   Google Scholar
• Australian National Aids and Injecting Drug Use Study. Neither a Borrower nor a Lender be: First Report of the Australian National AIDS and Injecting Drug Use Study, 1989 Data Collection. ANAIDUS, Sydney 1989
   Google Scholar
• Bell J., Digiusto E., Byth K. Who should receive methadone maintenance?. Br. J. Addict. 1992; 87: 689–694
   PubMedGoogle Scholar
• Blix O., Gröndbladh L. The impact of methadone maintenance treatment on the spread of HIV among IV heroin addicts in Sweden. Drug Addiction and AIDS, N. Loimer, R. Schmid, A. Springer. Springer-Verlag, New York 1991; pp. 200–205
   Google Scholar
• Brown L. S., Chu A., Memoto T., Ajuluchukwu D., Prim B. J. Human immunodeficiency virus infection in a cohort of intravenous drug users in New York City. N. Y. State J. Med. 1989; 89: 506–510
   PubMedGoogle Scholar
• Calsyn D. A., Saxon A. J., Freeman G., Whittaker S. Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. Am. J. Public Health 1992; 82: 573–575
   PubMed Web of Science ®Google Scholar
• Caplehorn J. R. M. A comparison of private and public methadone maintenance patients. Drug Alcohol Rev. 1992; 11: 43–49
   PubMedGoogle Scholar
• Caplehorn J. R. M. A comparison of abstinence-oriented and indefinite methadone maintenance treatment. Int. J. Addict. 1994; 29: 1361–1375
   PubMedGoogle Scholar
• Caplehorn J. R. M., Bell J., Kleinbaum D. G., Gebski V. J. Methadone dose and heroin use during maintenance treatment. Addiction 1993; 88: 113–124
   PubMed Web of Science ®Google Scholar
• Caplehorn J. R. M., Saunders J. B. Factors associated with heroin users' AIDS risk-taking behaviors. Aust. J. Public Health 1993; 17: 13–17
   PubMedGoogle Scholar
• Daniel A. Power, Privilege and Prestige: Occupations in Australia. Longman Cheshire, Melbourne 1983
   Google Scholar
• Gebski V. J., Leung O. K., McNeil D. R., Lunn A. D. SPIDA Users Manual (Version 6). Statistical Laboratory Macquarie University, Sydney 1992
   Google Scholar
• Klee H., Faugier J., Hayes C., Morris J. The sharing of injecting equipment among drug users attending prescribing clinics and those using needle-exchanges. Br. J. Addict. 1991; 86: 217–223
   PubMedGoogle Scholar
• Kleinbaum D. G., Kupper L. L., Muller K. E. Applied Regression Analysis and Other Multivariate Methods. PWS-Kent, Boston 1988
   Google Scholar
• Longshore D., Hsieh S., Danila B., Anglin M. D. Methadone maintenance and needle/syringe sharing. Int. J. Addict. 1993; 28: 983–996
   PubMed Web of Science ®Google Scholar
• Magura S., Grossman J. I., Lipton D. S. Determinants of needle sharing among intravenous drug users. Am. J. Public Health 1989; 79: 459–462
   PubMed Web of Science ®Google Scholar
• Marmor M., Des Jarlais D. C., Cohen H. Risk factors for infection with Human Immunodeficiency Virus among intravenous drug abusers in New York City. AIDS 1987; 1: 39–44
   PubMed Web of Science ®Google Scholar
• Martin G. S., Serpelloni G., Galvan U. Behavioural change in injecting drug users: Evaluation of an HIV/AIDS education programme. AIDS Care 1990; 2: 275–286
   PubMedGoogle Scholar
• McLellan A. T., Arndt I. O., Metzger D. S., Woody G. E., O'Brien C. P. The effects of psychosocial services in substance abuse treatment. JAMA 1993; 269: 1953–1959
   PubMed Web of Science ®Google Scholar
• Metzger D. S., Woody G. E., McLellan A. T. Human Immunodeficiency Virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up. J. Acquired Immune Deficiency Syndrome 1993; 6: 1049–1056
   PubMed Web of Science ®Google Scholar
• Sas Institute Inc. SAS/STAT User's Guide, Version 6, Fourth Edition, Volume 2. SAS Institute Inc., Cary, North Carolina 1989; p. 1090
   Google Scholar
• Selwyn P. A., Feiner C., Cox C. P., Lipshutz C., Cohen R. L. Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City. AIDS 1987; 1: 247–254
   PubMed Web of Science ®Google Scholar
• Serpelloni G., Carrieri M. P., Rezza G. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: A nested case-control study. AIDS Care 1994; 6: 215–220
   PubMed Web of Science ®Google Scholar
• Stark K., Muller R. HIV prevalence and risk behaviour in injecting drug users in Berlin. Forensic Sci. Int. 1993; 62: 73–81
   PubMed Web of Science ®Google Scholar
• Van Ameijden E. J. C., Van Den Hoek J. A. R., Coutinho R. A. Injecting risk behaviour among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. Am. J. Public Health 1994; 84: 275–281
   PubMed Web of Science ®Google Scholar
• Van Ameijden E. J. C., Van Den Hoek J. A. R., Van Haastrecht H. J. A., Coutinho R. A. The harm reduction approach and risk factors for Human Immunodeficiency Virus (HIV) seroconversion in injecting drug users, Amsterdam. Am. J. Epidemiol. 1992; 136: 236–243
   PubMed Web of Science ®Google Scholar
• Ward J., Mattick R. P., Hall W. Key Issues in Methadone Maintenance Treatment. University of New South Wales Press, Sydney 1992
   Google Scholar
• Williams A. B., McNelly E. A., Williams A. E., D'Aquila R. T. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users. AIDS Care 1992; 4: 35–41
   PubMed Web of Science ®Google Scholar
• Zangerle R., Fuchs D., Rössler H. Trends in HIV infection among intravenous drug users in Innsbruck, Austria. J. Acquired Immune Deficiency Syndrome 1992; 5: 865–871
   PubMedGoogle Scholar